Fosun International’s AbbVie ABBV Stock Holding History

Fosun International’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$961K	Hold	3,817	–	–	0.22%	44
2026 Q1	$830K	Buy	3,817 +1,790	+88%	+$397K	0.21%	36
2025 Q4	$463K	Hold	2,027	–	–	0.11%	39
2025 Q3	$469K	Buy	2,027 +687	+51%	+$140K	0.18%	34
2025 Q2	$247K	Buy	+1,340	New	+$249K	0.07%	51
2022 Q2	–	Sell	-3,600	Closed	-$590K	–	66
2022 Q1	$590K	Hold	3,600	–	–	0.05%	132
2021 Q4	$487K	Hold	3,600	–	–	0.03%	167
2021 Q3	$392K	Hold	3,600	–	–	0.02%	168
2021 Q2	$404K	Buy	3,600 +1,600	+80%	+$180K	0.02%	157
2021 Q1	$214K	Buy	+2,000	New	+$214K	0.02%	175
2019 Q3	–	Sell	-96,000	Closed	-$6.72M	–	228
2019 Q2	$6.72M	Buy	+96,000	New	+$7.55M	0.44%	34

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fosun International's ABBV Position: Q2 2026 in Review

Fosun International held its AbbVie (ABBV) position steady in Q2 2026 at 3,817 shares worth $961K. The position accounts for 0.22% of the portfolio, ranked #44.

Fosun International first reported a position in ABBV in Q2 2019 and has held it in 11 quarters since. The position peaked at $6.72M in Q2 2019. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fosun International held 3,817 shares of AbbVie worth $961K as of Q2 2026.
Fosun International left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.22% of Fosun International's portfolio in Q2 2026, its #44 holding.
Fosun International first reported a position in AbbVie in Q2 2019 and has held it in 11 quarters since.
Fosun International's AbbVie position peaked at $6.72M in Q2 2019.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fosun International's 13F filing for Q2 2026, filed 12 Aug 2026.